Characterization of a novel nuclear Rab protein
Characterization of a novel nuclear Rab protein
批准号:
7230197
负责人:
YING HUANG
金额:
$11.55万
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-04-01 至 2010-03-31
关键词:
AntibodiesApoptosisBreastCancer cell lineCell DeathCell NucleusCell SurvivalCellsCo-ImmunoprecipitationsCoupledCytoplasmic ProteinDataDepthDevelopmentDominant-Negative MutationDown-RegulationEventFamilyFamily memberFibroblastsFreezingFutureGTP BindingGTP-Binding ProteinsGenesGreen Fluorescent ProteinsGrowthHumanImmunoprecipitationLY294002LaboratoriesLocalizedMessenger RNAMolecularMolecular Mechanisms of ActionMusMutagensNamesNormal tissue morphologyNuclearOncogenicPTEN geneParaffin EmbeddingPathway interactionsPhosphatidylinositide 3-Kinase InhibitorPlayProtein FamilyProtein OverexpressionProteinsProteomicsRNA InterferenceReagentResearch PersonnelRoleSignal PathwaySignal TransductionSite-Directed MutagenesisSpecificitySpecimenStressSulindac SulfideSystemThapsigarginTissuesTransmembrane TransportUltraviolet RaysYeastsbasecarcinogenesiscell growthgenetic regulatory proteinhybrid proteininsightintracellular protein transportmRNA Expressionmalignant breast neoplasmmembermetaplastic cell transformationmutantnovelprogramsprotein transportrab GTP-Binding Proteinsresponsetraffickingtumorigenesisyeast two hybrid system
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Rab GTP-binding proteins are members of the Ras supergene family. Rab proteins are generally involved in protein transport/trafficking and determine the specificity of membrane transport steps within cell. We have identified a novel member of the Rab protein family, which we have named Nu-Rab, for its unique nuclear localization. Nu-Rab mRNA is highly expressed in most of cancer cell lines examined, and it is overexpressed in more than 60% of human primary breast cancers when compared to their matching normal tissues. The GFP- and Myc-tagged Nu-Rab mainly localizes to nucleus with some distribution noted in the cytoplasmic subcellular compartment. Immnunochemistry using Nu-Rab antibodies generated in our laboratory also detects that the endogenous Nu-Rab predominantly localizes to nucleus. Nu-Rab expression is down-regulated by apoptosis inducing agents such as ultraviolet radiation (UV), thapsigargin and sulindac sulfide. The PI3-kinase inhibitor LY294002, PI3-K phosphotase PTEN and dominant-negative mutant-Akt also down-regulate Nu-Rab mRNA expression, suggesting that Nu-Rab is a potential downstream target of the PI3-K/Akt signaling pathway. We are now proposing to further investigate the role of Nu-Rab in cell growth and/or survival and to elucidate the molecular basis of its overexpression in human breast cancer. In specific aim 1, we will analyze a larger pool of fresh-frozen and paraffin-embedded tissue specimens to evaluate the expression of Nu-Rab at the mRNA and protein levels. In specific aim 2, we will initiate functional studies to explore the effect of wild type-and GTP-binding mutants of Nu-Rab protein in oncogenic transformation. We will also explore whether Nu-Rab overexpression or deficiency effects apoptosis induced by genotoxic and non-genotoxic agents. Studies in specific aim 3 will be initiated to identify potential Nu-Rab effectors/regulator proteins in order to explore whether Nu-Rab plays a role in nuclear-cytoplasmic protein trafficking and study potential signaling events modulated by Nu-Rab. These are exploratory/developmental studies that, upon completion, will generate sufficient new data and reagents that will form the basis of future in-depth studies investigating the molecular mechanisms (s) of action of this novel GTP-binding protein in breast cancer development and/or progression.
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
DOI:
10.18632/genesandcancer.71
发表时间:
2015-07
期刊:
Genes & cancer
影响因子:
--
作者:
[Lui K, Sheikh MS, Huang Y]
通讯作者:
Huang Y
Role of a Novel Lysophospholipase in Tumorigenesis
-
批准号:8209218
-
项目类别:
-
资助金额:$28.44万
-
财政年份:2008
-
负责人:YING HUANG
-
依托单位:
Role of a Novel Lysophospholipase in Tumorigenesis
-
批准号:7599214
-
项目类别:
-
资助金额:$29.32万
-
财政年份:2008
-
负责人:YING HUANG
-
依托单位:
Role of a Novel Lysophospholipase in Tumorigenesis
-
批准号:7467584
-
项目类别:
-
资助金额:$29.32万
-
财政年份:2008
-
负责人:YING HUANG
-
依托单位:
Role of a Novel Lysophospholipase in Tumorigenesis
-
批准号:8018083
-
项目类别:
-
资助金额:$28.44万
-
财政年份:2008
-
负责人:YING HUANG
-
依托单位:
Role of a Novel Lysophospholipase in Tumorigenesis
-
批准号:7759205
-
项目类别:
-
资助金额:$29.32万
-
财政年份:2008
-
负责人:YING HUANG
-
依托单位:
Characterization of a putative GTP-binding protein as a novel tumor marker.
-
批准号:7266108
-
项目类别:
-
资助金额:$7.83万
-
财政年份:2007
-
负责人:YING HUANG
-
依托单位:
Characterization of a putative GTP-binding protein as a novel tumor marker.
-
批准号:7446107
-
项目类别:
-
资助金额:$7.85万
-
财政年份:2007
-
负责人:YING HUANG
-
依托单位:
Characterization of a novel nuclear Rab protein
-
批准号:7093752
-
项目类别:
-
资助金额:$11.78万
-
财政年份:2006
-
负责人:YING HUANG
-
依托单位:
Characterization of a novel ER membrane protein SPOC
-
批准号:6874380
-
项目类别:
-
资助金额:$15.2万
-
财政年份:2004
-
负责人:YING HUANG
-
依托单位:
Characterization of a novel ER membrane protein SPOC
-
批准号:6762103
-
项目类别:
-
资助金额:$15.2万
-
财政年份:2004
-
负责人:YING HUANG
-
依托单位:
Dielectrophoretic Separator for Cell/Pathogen Separation
-
批准号:6585295
-
项目类别:
-
资助金额:$14.75万
-
财政年份:2003
-
负责人:YING HUANG
-
依托单位:
Characterization of a Novel Lysophospholipase
-
批准号:6521908
-
项目类别:
-
资助金额:$15.2万
-
财政年份:2002
-
负责人:YING HUANG
-
依托单位:
Characterization of a Novel Lysophospholipase
-
批准号:6637079
-
项目类别:
-
资助金额:$15.2万
-
财政年份:2002
-
负责人:YING HUANG
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
-
批准号:LBY21H010001
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2020
-
负责人:郑绪阳
-
依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
-
批准号:81703335
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2017
-
负责人:卫高菲
-
依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
-
批准号:81670594
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2016
-
负责人:陈昊
-
依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
-
批准号:81470791
-
项目类别:面上项目
-
资助金额:73.0万元
-
批准年份:2014
-
负责人:董家鸿
-
依托单位:
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
-
批准号:81301123
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2013
-
负责人:王海莲
-
依托单位:
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
-
批准号:81101529
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:陈雪芹
-
依托单位:
放疗与细胞程序性死亡(APOPTOSIS)相关性及其应用研究
-
批准号:39500043
-
项目类别:青年科学基金项目
-
资助金额:9.0万元
-
批准年份:1995
-
负责人:梁克
-
依托单位: